Effect of Biased GLP-1/Glucagon Receptor Co-agonists on Insulin Secretion

被引：0
|
作者：
Farooq, Gala
Jones, Ben
Minnion, James S.
Bloom, Stephen R.
机构：
来源：
DIABETES | 2018年 / 67卷
关键词：
D O I：
10.2337/db18-1100-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A Dual GLP-1/GIP Receptor Agonist Does Not Antagonize Glucagon at Its Receptor but May Act as a Biased Agonist at the GLP-1 Receptor
    Al-Zamel, Noura
    Al-Sabah, Suleiman
    Luqmani, Yunus
    Adi, Lobna
    Chacko, Siby
    Schneider, Tom Dario
    Krasel, Cornelius
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (14)
  • [22] Is cardioprotection with GLP-1 receptor agonists a class effect?
    Ryden, Lars
    Ferrannini, Giulia
    Mellbin, Linda
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2021, 28 (01) : 18 - 21
  • [23] The Effect of GLP-1 Receptor Agonists on Postprandial Lipaemia
    Novodvorsky, Peter
    Haluzik, Martin
    CURRENT ATHEROSCLEROSIS REPORTS, 2022, 24 (01) : 13 - 21
  • [24] The Effect of GLP-1 Receptor Agonists on Postprandial Lipaemia
    Peter Novodvorský
    Martin Haluzík
    Current Atherosclerosis Reports, 2022, 24 : 13 - 21
  • [25] β-Arrestin-Biased Agonists of the GLP-1 Receptor from β-Amino Acid Residue Incorporation into GLP-1 Analogues
    Hager, Marlies V.
    Johnson, Lisa M.
    Wootten, Denise
    Sexton, Patrick M.
    Gellman, Samuel H.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2016, 138 (45) : 14970 - 14979
  • [26] Cardiovascular effects of Glucagon-like peptide 1 (GLP-1) receptor agonists
    Saraiva, Francisco Kerr
    Sposito, Andrei C.
    CARDIOVASCULAR DIABETOLOGY, 2014, 13
  • [27] GLP-1 receptor agonists in NAFLD
    Petit, J. -M.
    Verges, B.
    DIABETES & METABOLISM, 2017, 43 : 2S28 - 2S33
  • [28] GLP-1 receptor agonists and suicidality
    Ueda, Peter
    Pasternak, Bjorn
    BMJ-BRITISH MEDICAL JOURNAL, 2025, 388
  • [29] Cardiovascular effects of Glucagon-like peptide 1 (GLP-1) receptor agonists
    Francisco Kerr Saraiva
    Andrei C Sposito
    Cardiovascular Diabetology, 13
  • [30] Emerging GLP-1 receptor agonists
    Lund, Asger
    Knop, Filip K.
    Vilsboll, Tina
    EXPERT OPINION ON EMERGING DRUGS, 2011, 16 (04) : 607 - 618
12345